Background illustration for clinical trials search

Triple Negative Breast Cancer Clinical Trials

Browse 2,256 triple negative breast cancer clinical trials enrolling across the United States and Canada. Search by city or state to find one near you.

Filter
1

Prospective Study of oncRNA Stratification of Cancer by Size and Stage

for
Cancer
Location: Reno NV, Palo Alto CA
Sponsor: Exai Bio Inc.

Sex: All

Age: 18+

Code: NCT05833360

Recruiting

Post-Marketing Study for Early-Stage Low-Risk Breast Cancer Treatment Using ProSense® Cryoablation (ChoICE Trial)

for
Low-Risk, Early Stage Breast Cancer
Location: Germantown TN, Portland OR, Glendale CA
Sponsor: IceCure Medical Ltd.

Sex: All

Age: 70+

Code: NCT07629206

Recruiting

Trial Comparing LATTICE Radiotherapy vs Moderately Dose-escalated Palliative Radiation for Patients With Metastases.

for
Metastases, Metastatic Cancer
Location: Palo Alto CA
Sponsor: Stanford University

Sex: All

Age: 12+

Code: NCT07594431

Phase 2, Recruiting

Aromatherapy Essential Oils to Manage Anxiety and Nausea in Cancer Patients Receiving Infusion in the Ambulatory Setting

for
Hematopoietic and Lymphatic System Neoplasm,
Location: Irvine CA, Duarte CA
Sponsor: City of Hope Medical Center

Sex: All

Age: 18+

Code: NCT07126301

Recruiting

A Pilot Unrestricted Payment Program for Early-stage Cancer Patients: the PAYMENT Trial

for
Malignant Solid Neoplasm
Location: Vancouver WA, Longview WA
Sponsor: Fred Hutchinson Cancer Center

Sex: All

Age: 18+

Code: NCT06771739

Recruiting

Interested in new trials?

Get alerts for new trials in your area by subscribing now

Subscriber Image

B7-H3.CD28Z.CART in Solid Tumors

for
Pediatric Solid Tumor, Neuroblastoma
Location: Boston MA
Sponsor: Robbie Majzner

Sex: All

Age: 0 - 30

Code: NCT07358260

Phase 1, Recruiting

PREDICTT Clinical Trial: Prospective Evaluation Of Pressure-Enabled Delivery And Alterations In CT-Based Tumor-To-Normal Liver Ratio And Tumor Dose Using The Trinav Infusion System

for
Tumor, Liver
Location: Houston TX
Sponsor: M.D. Anderson Cancer Center

Sex: All

Age: 18+

Code: NCT07444645

Recruiting

A Study Evaluating the Efficacy and Safety of Inavolisib Plus Fulvestrant Compared With Alpelisib Plus Fulvestrant in Participants With HR-Positive, HER2-Negative, PIK3CA Mutated, Locally Advanced or Metastatic Breast Cancer Post CDK4/6i and Endocrine Combination Therapy

for
Breast Cancer
Location: Boston MA, Atlanta GA
Sponsor: Hoffmann-La Roche

Sex: All

Age: 18+

Code: NCT05646862

Phase 3, Recruiting

A Tailored Medication Adherence-Promotion Intervention for Adolescents and Young Adults With Cancer

for
Cancer, Medication Adherence
Location: Cincinnati OH, Seattle WA
Sponsor: Children's Hospital Medical Center, Cincinnati

Sex: All

Age: 15 - 24

Code: NCT07223463

Recruiting

First-in-Human Trial of VBC108 in Participants With Advanced Malignant Solid Tumors

for
Advanced Solid Tumors
Location: Fairfax VA, Grand Rapids MI, San Antonio TX, Duarte CA
Sponsor: VelaVigo Bio Inc

Sex: All

Age: 18+

Code: NCT07700160

Phase 1, Phase 2, Recruiting

Unified Network for Integrated Fluid Collection at Yale

for
Molecular Residual Disease, Cancer
Location: New Haven CT
Sponsor: Yale University

Sex: All

Age: 18+

Code: NCT07689864

Recruiting

Evaluation of Depression and Anxiety in Chemotherapy Patients

for
Oncology Problem
Location: Staten Island NY
Sponsor: Richmond University Medical Center

Sex: All

Age: 18 - 70+

Code: NCT03552731

Recruiting

BMS-986504 in Combination With Pemetrexed for the Treatment of Metastatic Solid Tumors With MTAP Deletion

for
Metastatic Biliary Tract Carcinoma, Metastatic Colon Carcinoma,
Location: Chicago IL
Sponsor: Northwestern University

Sex: All

Age: 18+

Code: NCT07594626

Phase 1, Phase 2, Recruiting

Researching the Effect of Exercise on Cancer

for
Breast Cancer, Prostate Cancer, Colorectal Cancer,
Location: Durate CA
Sponsor: City of Hope Medical Center

Sex: All

Age: 18+

Code: NCT04589468

Recruiting

BRIDGE-SIC Efficacy Trial

for
Cancer
Location: Boston MA
Sponsor: Dana-Farber Cancer Institute

Sex: All

Age: 18+

Code: NCT07735442

Recruiting

A Ph II Study of the TheraBionic P1 Device in Subjects With Hormone Positive Breast Cancer

for
HER2-negative Breast Cancer, Hormone Receptor Positive Tumor,
Location: Port Huron MI, Mount Clemens MI, Detroit MI, Lapeer MI,
Sponsor: Barbara Ann Karmanos Cancer Institute

Sex: All

Age: 22+

Code: NCT07227831

Recruiting

A Study of Romosozumab in People With Breast Cancer and Osteoporosis

for
Breast Cancer, Metastatic Breast Cancer (MBC)
Location: Commack NY, Uniondale NY, Harrison NY, New York NY,
Sponsor: Memorial Sloan Kettering Cancer Center

Sex: Female

Age: 18+

Code: NCT07776613

Phase 2, Recruiting

Indirect Calorimetry-Guided Parenteral Nutrition Prescribing in Oncology Patients

for
Malnutitrion, Cancer
Location: Philadelphia PA
Sponsor: Fox Chase Cancer Center

Sex: All

Age: 18+

Code: NCT07776704

Recruiting

Circulating Tumor DNA to Guide Changes in Standard of Care Chemotherapy

for
Metastatic HER2-Negative Breast Carcinoma,
Location: Nashville TN
Sponsor: Vanderbilt-Ingram Cancer Center

Sex: All

Age: 18+

Code: NCT05770531

Phase 2, Recruiting

A Phase I/IIa Study of AZD8205 Given Alone or Combined, in Participants With Advanced/Metastatic Solid Malignancies

for
Breast Cancer, Biliary Tract Carcinoma, Ovarian Cancer,
Location: Boston MA, Commack NY, Baltimore MD, Ottawa, Toronto,
Sponsor: AstraZeneca

Sex: All

Age: 18+

Code: NCT05123482

Phase 1, Phase 2, Recruiting

What is triple negative breast cancer?

Triple negative breast cancer, or TNBC, is breast cancer whose cells test negative for estrogen receptors, progesterone receptors, and excess HER2 protein, so hormone therapy and HER2 targeted drugs do not work against it. It tends to grow faster and is more common in women who have not gone through menopause, in Black women, and in people with an inherited BRCA1 mutation, so genetic testing is recommended for everyone diagnosed. In US data, five year relative survival is about 92 percent when it is found while localized, 67 percent with regional spread, and 15 percent once it has reached distant organs. Standard treatment for early stage disease is chemotherapy combined with immunotherapy before surgery, followed by more treatment after; metastatic disease is treated with chemotherapy, immunotherapy for PD-L1 positive tumors, and antibody drug conjugates. Other breast cancers are covered on our breast cancer clinical trials page.

Types of triple negative breast cancer clinical trials

Who can participate in triple negative breast cancer clinical trials?

Is triple negative breast cancer hereditary?

Stages of triple negative breast cancer, and why they matter for trials

How to enroll in a triple negative breast cancer clinical trial